26.34
-0.56
(-2.08%)
At close: 3:14:18 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
29,302.00
20,398.00
16,742.00
13,010.00
4,057.00
Cost of Revenue
7,958.00
6,035.00
4,331.00
4,986.00
1,162.00
Gross Profit
21,344.00
14,363.00
12,411.00
8,024.00
2,895.00
Operating Expense
17,410.00
14,903.00
21,363.00
22,166.00
20,910.00
Operating Income
3,934.00
-540.00
-8,952.00
-14,142.00
-18,015.00
Net Non Operating Interest Income Expense
-14,123.00
-15,623.00
-17,566.00
-10,667.00
-2,541.00
Other Income Expense
9,804.00
-9,640.00
16,227.00
-2,422.00
-10,381.00
Pretax Income
-385.00
-25,803.00
-10,291.00
-27,231.00
-30,937.00
Tax Provision
--
4.00
2.00
28.00
--
Net Income Common Stockholders
-389.00
-25,807.00
-10,293.00
-27,259.00
-30,937.00
Diluted NI Available to Com Stockholders
-389.00
-25,807.00
-10,293.00
-27,259.00
-30,937.00
Basic EPS
6.98
-11.25
-7.50
-18.75
-30.00
Diluted EPS
6.98
-11.25
-7.50
-18.75
-30.00
Basic Average Shares
3,109.19
2,116.94
1,465.26
1,382.28
1,008.34
Diluted Average Shares
3,109.19
2,116.94
1,465.26
1,382.28
1,008.34
Total Operating Income as Reported
3,934.00
-540.00
-8,952.00
-14,142.00
-25,200.00
Total Expenses
25,368.00
20,938.00
25,694.00
27,152.00
22,072.00
Net Income from Continuing & Discontinued Operation
-389.00
-25,807.00
-10,293.00
-27,259.00
-30,937.00
Normalized Income
-8,283.00
-18,206.41
-23,119.44
-25,490.94
-19,956.00
Interest Expense
14,123.00
15,623.00
14,132.00
7,095.00
2,541.00
Net Interest Income
-14,123.00
-15,623.00
-17,566.00
-10,667.00
-2,541.00
EBIT
13,738.00
-10,180.00
3,841.00
-20,136.00
-28,396.00
EBITDA
14,722.00
-9,152.00
4,793.00
-18,900.00
-27,384.00
Reconciled Cost of Revenue
7,731.00
5,759.00
4,145.00
4,534.00
931.00
Reconciled Depreciation
984.00
1,028.00
952.00
1,236.00
1,012.00
Net Income from Continuing Operation Net Minority Interest
-389.00
-25,807.00
-10,293.00
-27,259.00
-30,937.00
Total Unusual Items Excluding Goodwill
7,894.00
-9,621.00
16,236.00
-2,422.00
-10,981.00
Total Unusual Items
7,894.00
-9,621.00
16,236.00
-2,422.00
-10,981.00
Normalized EBITDA
6,828.00
469.00
-11,443.00
-16,478.00
-16,403.00
Tax Rate for Calcs
--
0.00
0.00
0.00
--
Tax Effect of Unusual Items
--
-2,020.41
3,409.56
-653.94
--
12/31/2020 - 11/11/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MODD Modular Medical, Inc.
1.2200
+2.52%
KLYG Kelyniam Global, Inc.
0.2100
+5.00%
EVMT.V Evome Medical Technologies Inc.
0.1400
0.00%
NMTC NeuroOne Medical Technologies Corporation
1.0401
-1.88%
MXCT MaxCyte, Inc.
4.7500
-1.45%
CLPT ClearPoint Neuro, Inc.
14.96
-1.03%
USAQ QHSLab, Inc.
0.2400
-10.71%
ECOR electroCore, Inc.
15.70
0.00%
CVRX CVRx, Inc.
17.30
+1.76%
ICAD iCAD, Inc.
1.9000
+1.06%